Facebook
Twitter
LinkedIn
ForwardBipolar Disorder Management in a Perinatal Patient
Overview
Register For Zoom Link
To receive the link to the Zoom webinar, please register here.
Join The Periscope Project for our 2025 webinar series dedicated to building capacity to address mental health conditions in pregnant and postpartum patients. This series covers a wide range of topics related to perinatal mental health. The series is intended for health care providers/professionals interacting with people during any point in the perinatal period: pre-pregnancy through one year postpartum. Webinars take place via Zoom from 12pm-1pm CST. This webinar series is offered at no cost to participants.
The Periscope Project is a statewide provider-to-provider perinatal psychiatric access program. It offers three core services to build capacity in front-line health care providers to manage mental health conditions in pregnant, postpartum, and preconception patients:
- Provider to Perinatal Psychiatrist consultation within 30 minutes Monday – Friday 8 am to 4 pm.
- Linkages with community-based resources that support perinatal women’s mental health.
- Education and training for providers and staff on evidence-based treatment of perinatal psychiatric conditions.
Periscope can help OB/GYNs, midwives, family medicine, psychiatrists, and pediatricians by providing:
- Support with caring for perinatal patients with mental health needs.
- Health care providers with a treatment plan to bridge patients to psychiatric care.
- Education on perinatal mental health diagnosis and treatment.
- Reassurance on treatment of perinatal mental health disorders.
- Connections for patients to local mental health resources.
Target Audience
- Physicians
- Psychologists
- Physician Assistants
- Nurse Practitioners
Learning Objectives
Participants who engage in this educational intervention will be able to:
- Identify risks of untreated bipolar disorder in pregnancy.
- Describe link between postpartum psychosis and bipolar disorder discuss common treatments (e.g. lithium, valproic acid, carbamazepine, lamotrigine, class of atypical antipsychotics).
- Describe risks to the fetus and newborn of exposure to mood stabilizers (e.g. lithium, valproic acid, carbamazepine, lamotrigine, class of atypical antipsychotics) in utero.
Venue
Faculty
Activity Director:
Christina L. Wichman, DO
Professor of Psychiatry and Obstetrics and Gynecology
Vice Chair of Education, Department of Psychiatry and Behavioral Medicine
Medical Director, The Periscope Project
Co-Director, Women's Mental Health
Program Director, Consultation-Liaison Psychiatry Fellowship
Program Director, Northeastern Wisconsin Psychiatry Residency
Medical College of Wisconsin
Planning Committee Members:
Jason Ipsarides, DNP, PMHNP-BC
Assistant Professor of Psychiatry
Medical College of Wisconsin
Speaker:
Christina L. Wichman, DO
Professor of Psychiatry and Obstetrics and Gynecology
Vice Chair of Education, Department of Psychiatry and Behavioral Medicine
Medical Director, The Periscope Project
Co-Director, Women's Mental Health
Program Director, Consultation-Liaison Psychiatry Fellowship
Program Director, Northeastern Wisconsin Psychiatry Residency
Medical College of Wisconsin
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all persons in control of content must disclose any relevant financial relationships. It is the policy of the Medical College of Wisconsin to identify, mitigate and disclose the absence or presence of all relevant financial relationships with ineligible companies held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education. The following in control of content had no relevant financial relationships to disclose.
- Christina L. Wichman
- Jason Ipsarides
Accreditation
ACCME ACCREDITATION STATEMENT
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA CREDIT DESIGNATION STATEMENT
The Medical College of Wisconsin designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
HOURS OF PARTICIPATION FOR ALLIED HEALTH CARE PROFESSIONALS
The Medical College of Wisconsin designates this activity for up to 1 hour of participation for continuing education for allied health professionals.
Nurse Practitioner:
Medical College of Wisconsin, Inc. is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 150930. This program has been approved for up to 1 contact hours of continuing education (which includes 0.75 hours of pharmacology). Nurse Practitioners should claim only those hours actually spent participating in the CME activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.
- 0.75 NP PharmacologyNP Pharmacology credit.
- 1.00 NP Contact Hours
Register/Take course
Price
Do I already have an account?
Have you ever used ocpe.mcw.edu? For example, if you have taken an activity accredited by the Medical College of Wisconsin, then you already have an account.
If you have forgotten your username/password, you can
retrieve it now